SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PAPI, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.425
EU - Europa 6.854
AS - Asia 5.413
OC - Oceania 109
AF - Africa 40
SA - Sud America 32
Continente sconosciuto - Info sul continente non disponibili 19
Totale 40.892
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.330
CN - Cina 2.475
UA - Ucraina 1.747
IT - Italia 1.404
SG - Singapore 1.217
TR - Turchia 1.008
DE - Germania 941
GB - Regno Unito 792
NL - Olanda 496
FI - Finlandia 480
SE - Svezia 473
ID - Indonesia 338
PL - Polonia 153
FR - Francia 121
AU - Australia 100
VN - Vietnam 96
CA - Canada 77
IN - India 70
CZ - Repubblica Ceca 42
BE - Belgio 39
HK - Hong Kong 30
TW - Taiwan 27
RU - Federazione Russa 23
JP - Giappone 22
KR - Corea 22
IE - Irlanda 20
PK - Pakistan 20
ES - Italia 19
IQ - Iraq 16
LT - Lituania 16
AT - Austria 15
IR - Iran 14
EU - Europa 13
EG - Egitto 12
CH - Svizzera 11
PH - Filippine 10
RO - Romania 10
BR - Brasile 9
NZ - Nuova Zelanda 9
PT - Portogallo 9
CO - Colombia 8
GR - Grecia 8
HU - Ungheria 8
VI - Stati Uniti Isole Vergini 8
HR - Croazia 7
KE - Kenya 7
MY - Malesia 7
ZA - Sudafrica 7
MK - Macedonia 6
MX - Messico 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
IL - Israele 5
PE - Perù 5
RS - Serbia 5
SA - Arabia Saudita 5
BD - Bangladesh 4
GE - Georgia 4
NP - Nepal 4
XK - ???statistics.table.value.countryCode.XK??? 4
AR - Argentina 3
BO - Bolivia 3
LA - Repubblica Popolare Democratica del Laos 3
NG - Nigeria 3
PA - Panama 3
ZW - Zimbabwe 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
MA - Marocco 2
MG - Madagascar 2
MZ - Mozambico 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
AL - Albania 1
BY - Bielorussia 1
DK - Danimarca 1
DZ - Algeria 1
HN - Honduras 1
IS - Islanda 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 40.892
Salva come PNG Salva come JPEG
Città #
Fairfield 4.047
Woodbridge 3.629
Houston 2.610
Jacksonville 2.032
Ashburn 1.840
Chandler 1.631
Seattle 1.489
Wilmington 1.427
Ann Arbor 1.326
Cambridge 1.317
Santa Clara 1.080
Singapore 934
Izmir 696
Nanjing 629
Princeton 564
San Diego 367
Jakarta 328
Beijing 313
Ferrara 311
Boardman 284
Washington 233
Milan 213
Nanchang 192
Shanghai 172
Los Angeles 171
Shenyang 166
New York 159
Warsaw 148
Addison 131
Tianjin 125
Hebei 124
Dearborn 108
Changsha 103
Jiaxing 100
London 96
Dong Ket 90
Mountain View 86
Falls Church 79
Redwood City 74
Lappeenranta 67
Norwalk 66
Zhengzhou 62
Kunming 50
Bremen 49
Helsinki 49
Jinan 49
Ningbo 46
Orange 45
Munich 44
Guangzhou 42
Rome 40
Brussels 38
San Mateo 36
Verona 36
Chicago 35
Frankfurt am Main 33
Bologna 32
Auburn Hills 31
Taizhou 31
Brno 29
Toronto 28
Lanzhou 27
Des Moines 26
Paris 25
Beauharnois 24
Philadelphia 20
Sydney 20
Changchun 19
Hangzhou 19
Tappahannock 18
Brisbane 16
Hong Kong 16
Perth 16
Indiana 15
Kilburn 15
Melbourne 15
Redmond 15
Augusta 14
Parma 14
Florence 13
Hefei 13
Olomouc 13
Taipei 13
Adelaide 12
Ferrara di Monte Baldo 12
Wuhan 12
Acton 11
Council Bluffs 11
Napoli 11
Pordenone 11
Vienna 11
Hounslow 10
Naples 10
Oristano 10
Padova 10
Chiswick 9
Istanbul 9
Walnut 9
Bogotá 8
Catania 8
Totale 30.922
Salva come PNG Salva come JPEG
Nome #
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 569
Asthma 410
Value of fiberoptic bronchoscopy in addition to 18F-FDG-PET/CT in the differentiation of solitary pulmonary nodules: a prospective study 305
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 264
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review 175
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial 172
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD 169
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 165
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 162
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 150
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma 150
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum 141
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells 141
COPD: early diagnosis and treatment to slow disease progression 140
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial 139
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 139
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 139
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 138
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma 138
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 135
Malattie polmonari primitive da cause dismetaboliche. 135
Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations 135
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 134
Models of infection and exacerbations in COPD. 133
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules 133
Deficient antiviral immune responses in childhood: Distinct roles of atopy and asthma 131
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 131
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD. 130
Efficacy of fluticasone propionate/formoterol fumarate in the treatment of asthma: A pooled analysis. 130
Rhinovirus vaccination: the case against 129
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats 128
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial 127
Management of bronchial asthma 125
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial 125
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 124
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 124
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease 123
Morte per asma. Parte I: fenotipi clinici, epidemiologia e fattori di rischio. 122
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 122
Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS. 122
Emphysema contribution to the progression of chronic obstructive pulmonary disease. 121
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthma. 121
Combination treatment in asthma: Reviewing old and new options 121
null 121
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 120
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease 120
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 120
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy 119
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes 119
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis 118
A human rhinovirus model of chronic obstructive pulmonary disease exacerbations 118
null 118
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 117
null 117
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 117
Mechanisms of rhinovirus-induced asthma. 116
Slower rise of exhaled breath temperature in chronic obstructive pulmonary disease 115
Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation 115
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 115
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. 115
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production 114
Airway inflammation and illness severity in response to experimental rhinovirus infection in asthma. 114
null 114
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma 114
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma 113
COPD exacerbations: definitions and classifications 112
B Cell Activating Factor (BAFF) Is Expressed by Lymphoid Follicles of COPD Patients 112
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 112
Reducing Agents Decrease the Oxidative Burst and Improve Clinical Outcomes in COPD Patients: A Randomised Controlled Trial on the Effects of Sulphurous Thermal Water Inhalation. 112
Protection of erdosteine on smoke‐induced peripheral neutrophil dysfunction both in healthy and in bronchitic smokers 111
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients. 111
null 111
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline 111
Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells 110
Severe asthma: Phenotyping to endotyping or vice versa? 110
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 110
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 110
Clinical definition of COPD exacerbations and classification of their severity 109
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. 109
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 109
A valid option for asthma control: Clinical evidence on efficacy and safety of fluticasone propionate/formoterol combination in a single inhaler 109
Prevention of COPD exacerbations: A European Respiratory Society/ American Thoracic Society guideline 109
Dual Bronchodilation Response by Exacerbation History and Eosinophilia in the FLAME Study 109
Management of patients with early mild asthma and infrequent symptoms 109
The future of relievers and controllers in asthma therapy. 109
The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics 108
Extrafine beclomethasone dipropionate/formoterol hydrofluoroalkane-propelled inhaler in asthma. 108
Circulating endothelial stem cells are not decreased in pulmonary emphysema or COPD 108
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study 108
Bronchopulmonary inflammation and airway smooth muscle hyperresponsiveness induced by nitrogen dioxide in guinea pigs 108
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 107
Oxidants in asthma and in chronic obstructive pulmonary disease (COPD) 107
Enfisema polmonare: prospettive di terapia 106
Near-fatal asthma phenotype in the ENFUMOSA Cohort. 106
Respiratory virus induction of alpha-, beta- and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. 106
Short term efficacy of nebulized beclomethasone in mild-to-moderate wheezing episodes in pre-school children 106
Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial. 106
Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. 106
Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. 105
A defective type 1 response to rhinovirus in atopic asthma 104
Totale 13.239
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 9.904
Totale 223.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.688 0 0 0 0 666 1.283 806 959 737 752 289 196
2020/20216.478 437 479 305 731 321 681 279 751 170 784 881 659
2021/20225.146 219 452 320 258 197 236 283 293 204 380 461 1.843
2022/20234.213 575 103 145 491 619 645 179 385 531 65 314 161
2023/20242.742 248 267 113 83 137 279 78 136 88 259 348 706
2024/20253.180 303 293 998 331 1.255 0 0 0 0 0 0 0
Totale 41.971